カテゴリ： GlobalData, アメリカ, 企業調査

Mayo Clinic：製薬・医療：M&Aディール及び事業提携情報

◆英語タイトル：Mayo Clinic - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA904C3029
◆発行会社（調査会社）：GlobalData
◆発行日：2018年8月
◆ページ数：133
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in most of the major disease categories and health disorders. It conducts active human research studies and new human research studies approved by institutional review at its facilities. The organization also operates several colleges of medicine which offer various residency and fellowship programs. Its other major facilities include Mayo Arizona, Mayo Minnesota, and Mayo Clinic Health System, a network of clinics and hospitals in several states. Mayo is headquartered in Jacksonville, Florida, the US.

Mayo Clinic – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8
Mayo Clinic, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 9
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 11
Mayo Clinic, Medical Devices Deals, 2012 to YTD 2018 12
Mayo Clinic, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Mayo Clinic, Pharmaceuticals & Healthcare, Deal Details 18
Venture Financing 18
Helix Opco Raises USD200 Million in Series B Financing 18
Unity Biotech Raises Additional USD35 Million in Series B Financing 20
Qrativ Raises USD8.3 Million in Series A Financing 22
Evelo Biosciences Raises USD50 Million in Series B Financing 23
DayTwo Secures USD12 Million in Series A Funding 25
DayTwo Raises USD12 Million in Series A Financing 26
UNITY Biotech Raises USD116 Million in Series B Financing 27
Second Genome Raises USD42.6 Million in Series B Financing 29
Unity Biotechnology Raises Funds in Venture Financing 31
AssureRx Health Raises Additional USD15 Million in Series D Financing 32
AssureRx Health Raises USD30 Million in Venture Financing Round 33
Chrono Therapeutics Raises USD32 Million in Series A Venture Financing 35
Seres Health Raises USD10 Million in Series B Financing 37
AssureRx Health Raises USD7 Million in Venture Financing 39
OxThera Raises US$10.7 Million In Venture Financing 41
Omnis Pharma Raises Funds in Seed Financing 42
AssureRx Health Raises US$12.5 Million In Series C Financing 43
Partnerships 45
SkylineDx Enters into Co-Development Agreement with Mayo Clinic 45
Sphingotec Enters into Collaboration Agreement with Mayo Clinic 46
Mayo Clinic and nference Form Joint Venture 47
Baxter International and Mayo Clinic Enter into Research Agreement 48
Evelo Biosciences Enters into Research Agreement with Mayo Clinic 49
EnBiotix Partners with Mayo Clinic 50
Seres Therapeutics Enters into Research Agreement with Mayo Clinic 51
Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 52
GE Ventures Forms Joint Venture with Mayo Clinic 53
Morphotek Enters into Agreement with Mayo Clinic 54
Mayo Clinic Forms Joint Venture with Hillhouse Capital 55
Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine 56
Mayo Clinic Forms Joint Venture with Delos Living 57
Enterome Enters into Co-Development Agreement with Mayo Clinic 58
Seres Health Enters into Research Agreement with Mayo Clinic 59
Mayo Clinic Enters Into Co-Development Agreement With Banner Health For Diagnostic Tests 60
Mayo Clinic Forms Joint Venture With Cancer Genetics 61
Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 63
Silicon Valley Biosystems Enters Into Agreement With Mayo Clinic For Genome Diagnostics 64
Optum Enters Into Joint Venture Agreement With Mayo Clinic 65
Mayo Clinic Enters Into Joint Venture With Select Medical To Form Allevant Solutions 66
Licensing Agreements 67
Elysium Health Enters into Licensing Agreement with Mayo Clinic and Harvard University 67
Imugene Enters into Licensing Agreement with Ohio State University Wexner Medical Center and Mayo Clinic 68
Evelo Biosciences Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 69
Mayo Clinic Enters into Licensing Agreement with ID Pharma 71
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic 72
Omnis Pharma Enters into Licensing Agreement with Mayo Clinic Ventures 73
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 74
Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 75
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 76
WuXi Pharma Enters Into Licensing Agreement With Mayo Clinic Center for Individualized Medicine 77
Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 78
Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 79
Acquisition 80
Mayo Clinic Acquires Dartmouth-Hitchcock Medical Center 80
Mayo Clinic Health System Completes Acquisition Of Fairview Red Wing 82
Mayo Clinic – Key Competitors 83
Mayo Clinic – Key Employees 84
Mayo Clinic – Locations And Subsidiaries 85
Head Office 85
Other Locations & Subsidiaries 85
Joint Venture 87
Recent Developments 88
Strategy And Business Planning 88
May 10, 2018: Vyriad to Build State-of-the-Art Facility for Manufacturing Oncolytic Virus Anti-Cancer Vaccines in Rochester, Minn. 88
Jul 14, 2017: Mayo Clinic, nference Launch a Startup to Discover, Develop Treatments for Diseases with Unmet Medical Need 89
Legal and Regulatory 91
Jun 25, 2018: Court Agrees with Atrium Health, Rejecting Attempt by Mednax to Disrupt Transition to New Anesthesia Partner 91
Jan 09, 2018: FDA clears way for Mayo Clinic to accelerate production of stem cells for clinical trials through automation 92
Government and Public Interest 93
Aug 01, 2018: Number of opioid prescriptions remains unchanged, Mayo Clinic research finds 93
Jul 30, 2018: FSU faculty awarded $226M in research dollars 95
Jul 25, 2018: Drug for Alzheimer’s disease shows early promise 96
Jun 21, 2018: Unusually High Levels of Herpesviruses Found in the Alzheimer’s Disease Brain, Mount Sinai Researchers Report 97
Jun 19, 2018: Mayo Clinic discovers gene mutations linked to pancreatic cancer, calls for expanded testing 99
May 31, 2018: Hyundai Hope On Wheels Announces Four Quantum Award Grant Recipients To Receive A Total Funding Of $5.5 Million Towards Pediatric Cancer Research 100
May 23, 2018: Foundation for Anesthesia Education and Research Awards $1.4 million in Grants 102
May 18, 2018: Biotin supplements caused misleading test results, almost led to unnecessary procedure 105
May 01, 2018: Mayo Clinic joins NIH in launching All of Us Research Program 106
Feb 21, 2018: Early results from clinical trials not all they’re cracked up to be, shows new research 107
Jan 25, 2018: Research test identifies BRCA2 gene mutations that lead to breast, ovarian cancers 108
Jan 17, 2018: Patients with blood cancer precursor at risk of developing cancer even after 30 years 109
Jan 03, 2018: Research finds hysterectomy alone associated with increased long-term health risks 110
Dec 11, 2017: USC, Harvard-affiliated hospitals & Mayo Clinic team up to streamline Alzheimer’s research 111
Nov 01, 2017: New Study Links Severe Hot Flashes With Greater Risk of Obstructive Sleep Apnea 113
Oct 24, 2017: Proton therapy may be better option for elderly patients with esophageal cancer 114
Sep 25, 2017: Halving radiation therapy for HPV-related throat cancer offers fewer side effects, similar outcomes 115
Sep 18, 2017: Scientists Discover Novel Mechanism Underlying ALS and Related Dementia 116
Aug 29, 2017: Study finds hormone therapy improves sleep quality for recently menopausal women 117
Aug 25, 2017: Study identifies genes linked to better immune response to flu vaccine 118
May 02, 2017: Mayo Clinic researchers develop new tumor-shrinking nanoparticle to fight cancer, prevent recurrence 119
Jan 09, 2017: Mayo Clinic researchers identify new potential treatment for cancer metastasis 120
Product News 121
Nov 20, 2017: New oral anticoagulant drugs associated with lower kidney risks, Mayo Clinic research shows 121
Nov 01, 2017: Mayo Clinic researchers find genetic pathways to individualized treatment for advanced prostate cancer 123
Jul 09, 2018: Senolytics Improve Health, Extend life: Preclinical research findings 124
Jul 02, 2018: Mayo researchers find off/on switch for DNA repair protein 125
May 16, 2018: Mayo study identifies new potential treatment option for triple negative breast cancer 126
May 16, 2018: Mayo discovery means individualized ovarian, brain cancer therapies 127
May 03, 2017: Mayo Clinic-invented technologies show brain tumor firmness, adhesion before surgery 128
Mar 08, 2018: Mayo Clinic’s clinical trial matching project sees higher enrollment in breast cancer trials through use of artificial intelligence 129
Other Significant Developments 130
Aug 15, 2018: Healthcare Innovators professional society reaches member goal of 33 top industry executives for nationwide council 130
Jun 15, 2018: Mayo Clinic brings national Smithsonian exhibit to Rochester Art Center 131
Apr 03, 2018: Mayo Clinic to coordinate new effort to expand medical research, expert care for Lewy body dementia patients 132
Appendix 133
Methodology 133
About GlobalData 133
Contact Us 133
Disclaimer 133

List of Tables
Mayo Clinic, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8
Mayo Clinic, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 9
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10
Mayo Clinic, Deals By Therapy Area, 2012 to YTD 2018 11
Mayo Clinic, Medical Devices Deals, 2012 to YTD 2018 12
Mayo Clinic, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Helix Opco Raises USD200 Million in Series B Financing 18
Unity Biotech Raises Additional USD35 Million in Series B Financing 20
Qrativ Raises USD8.3 Million in Series A Financing 22
Evelo Biosciences Raises USD50 Million in Series B Financing 23
DayTwo Secures USD12 Million in Series A Funding 25
DayTwo Raises USD12 Million in Series A Financing 26
UNITY Biotech Raises USD116 Million in Series B Financing 27
Second Genome Raises USD42.6 Million in Series B Financing 29
Unity Biotechnology Raises Funds in Venture Financing 31
AssureRx Health Raises Additional USD15 Million in Series D Financing 32
AssureRx Health Raises USD30 Million in Venture Financing Round 33
Chrono Therapeutics Raises USD32 Million in Series A Venture Financing 35
Seres Health Raises USD10 Million in Series B Financing 37
AssureRx Health Raises USD7 Million in Venture Financing 39
OxThera Raises US$10.7 Million In Venture Financing 41
Omnis Pharma Raises Funds in Seed Financing 42
AssureRx Health Raises US$12.5 Million In Series C Financing 43
SkylineDx Enters into Co-Development Agreement with Mayo Clinic 45
Sphingotec Enters into Collaboration Agreement with Mayo Clinic 46
Mayo Clinic and nference Form Joint Venture 47
Baxter International and Mayo Clinic Enter into Research Agreement 48
Evelo Biosciences Enters into Research Agreement with Mayo Clinic 49
EnBiotix Partners with Mayo Clinic 50
Seres Therapeutics Enters into Research Agreement with Mayo Clinic 51
Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 52
GE Ventures Forms Joint Venture with Mayo Clinic 53
Morphotek Enters into Agreement with Mayo Clinic 54
Mayo Clinic Forms Joint Venture with Hillhouse Capital 55
Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine 56
Mayo Clinic Forms Joint Venture with Delos Living 57
Enterome Enters into Co-Development Agreement with Mayo Clinic 58
Seres Health Enters into Research Agreement with Mayo Clinic 59
Mayo Clinic Enters Into Co-Development Agreement With Banner Health For Diagnostic Tests 60
Mayo Clinic Forms Joint Venture With Cancer Genetics 61
Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 63
Silicon Valley Biosystems Enters Into Agreement With Mayo Clinic For Genome Diagnostics 64
Optum Enters Into Joint Venture Agreement With Mayo Clinic 65
Mayo Clinic Enters Into Joint Venture With Select Medical To Form Allevant Solutions 66
Elysium Health Enters into Licensing Agreement with Mayo Clinic and Harvard University 67
Imugene Enters into Licensing Agreement with Ohio State University Wexner Medical Center and Mayo Clinic 68
Evelo Biosciences Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 69
Mayo Clinic Enters into Licensing Agreement with ID Pharma 71
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic 72
Omnis Pharma Enters into Licensing Agreement with Mayo Clinic Ventures 73
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 74
Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 75
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 76
WuXi Pharma Enters Into Licensing Agreement With Mayo Clinic Center for Individualized Medicine 77
Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 78
Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 79
Mayo Clinic Acquires Dartmouth-Hitchcock Medical Center 80
Mayo Clinic Health System Completes Acquisition Of Fairview Red Wing 82
Mayo Clinic, Key Competitors 83
Mayo Clinic, Key Employees 84
Mayo Clinic, Other Locations 85
Mayo Clinic, Subsidiaries 85
Mayo Clinic, Joint Venture 87

List of Figures
Mayo Clinic, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8
Mayo Clinic, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 9
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 11
Mayo Clinic, Medical Devices Deals, 2012 to YTD 2018 12

★海外企業調査レポート[Mayo Clinic：製薬・医療：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Euro India Fresh Foods Ltd (EIFFL)：企業の財務・戦略的SWOT分析
    Euro India Fresh Foods Ltd (EIFFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Probi AB (PROB)：企業の財務・戦略的SWOT分析
    Probi AB (PROB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Sartorius Stedim Biotech SA (DIM)：企業の財務・戦略的SWOT分析
    Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • BioMar Group AS：企業の戦略的SWOT分析
    BioMar Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Offshore Oil Engineering Co Ltd (600583)：石油・ガス：M&Aディール及び事業提携情報
    Summary Offshore Oil Engineering Co Ltd (COOEC), a subsidiary of China National Offshore Oil Corp, is a general engineering contractor that offers offshore engineering construction services. The company’s services include engineering, procurement, construction, installation, maintenance and underwat …
  • Netcare Ltd (NTC)：企業の財務・戦略的SWOT分析
    Summary Netcare Ltd (Netcare) is a healthcare service provider that offers patient care services. The center provides medical facilities and treatments in the fields of breast care, oncology, orthopedics, renal care, transplants and weight management. Its facilities include medicross centers, netcar …
  • Doosan Heavy Industries & Construction Co Ltd (034020)：電力：M&Aディール及び事業提携情報
    Summary Doosan Heavy Industries & Construction Co Ltd (Doosan Heavy Industries), a subsidiary of Doosan Corporation, is a power plant equipment manufacturer. It offers integrated equipment and solutions for power and water plants. The company’s major products include boilers, generators, engines, tu …
  • Continental Resources Inc (CLR)：企業の財務・戦略的SWOT分析
    Summary Continental Resources Inc (Continental Resources) is an independent upstream oil and gas company. The company explores for, develops and produces crude oil and natural gas. It operates in the onshore oil field, the Bakken of North Dakota and Montana; SCOOP play in Woodford reservoir; SCOOP S …
  • Lifetime Brands, Inc. (LCUT)：企業の財務・戦略的SWOT分析
    Lifetime Brands, Inc. (LCUT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Entera Bio Ltd (ENTX)：製薬・医療：M&Aディール及び事業提携情報
    Summary Entera Bio Ltd (Entera Bio) is a clinical-stage biopharmaceutical company that provides development and commercialization of a novel drug delivery platform for bone healing. The company develops novel drug delivery platform for oral delivery of large molecule protein active pharmaceutical in …
  • Quickstep Holdings Limited：企業の戦略・SWOT・財務情報
    Quickstep Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Quickstep Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Howden Joinery Group Plc：企業の戦略・SWOT・財務情報
    Howden Joinery Group Plc - Strategy, SWOT and Corporate Finance Report Summary Howden Joinery Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Grand Gulf Energy Ltd (GGE)：企業の財務・戦略的SWOT分析
    Summary Grand Gulf Energy Ltd (GGE), formerly Alto Energy International Ltd, is an oil and gas exploration and production company. It acquires, explores and develops conventional oil and gas assets in the US oil and gas basins. In addition, GGE also holds interests in Napoleonville Salt Dome project …
  • Freeport-McMoRan Inc：企業の戦略・SWOT・財務情報
    Freeport-McMoRan Inc - Strategy, SWOT and Corporate Finance Report Summary Freeport-McMoRan Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Electronic Arts Inc. (EA)：企業の財務・戦略的SWOT分析
    Electronic Arts Inc. (EA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Canon Machinery Inc：企業の戦略的SWOT分析
    Canon Machinery Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Xintela AB (XINT)：企業の財務・戦略的SWOT分析
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also p …
  • EryDel SPA：製薬・医療：M&Aディール及び事業提携情報
    Summary EryDel SPA (EryDel), a subsidiary of Genextra Spa is a drug delivery company that develops drugs and diagnostics delivered through human red blood cells using a proprietary medical device technology. The company’s products include red cell loaders, and disposable kits for drug encapsulation …
  • Diagnostics For All Inc：企業の製品パイプライン分析
    Summary Diagnostics For All Inc (DFA) is a drug development company that develops and commercializes of new technology and practical diagnostic devices for diagnostic companies. The company uses patterned paper technology to create electrochemical clinical chemistry assays, immunoassays, assays, and …
  • Global Marine Systems Ltd-エネルギー分野：企業M&A・提携分析
    Summary Global Marine Systems Limited (Global Marine), a subsidiary of Bridgehouse Marine Limited, is a marine technology and engineering company. It provides submarine cable installation, maintenance and engineering services. Its capabilities include project management, subsea cable installation, s …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆